Literature DB >> 32901418

Comparison of planar with tomographic pyrophosphate scintigraphy for transthyretin cardiac amyloidosis: Perils and pitfalls.

Talal Asif1, Javier Gomez1,2, Vasvi Singh3,4,5, Rami Doukky1,2, Arlet Nedeltcheva1, Saurabh Malhotra6,7,8.   

Abstract

BACKGROUND: Tc-99m pyrophosphate (PYP) SPECT is recommended for indeterminate findings on planar imaging. We aimed to compare the findings on planar PYP scintigraphy alone to that of routinely performed PYP SPECT.
METHODS: PYP scintigraphy data of 133 patients (53% men; mean age 76 years) were evaluated. SPECT was routinely performed following 1-hour planar imaging, in all cases. Semiquantitative visual score and heart-to-contralateral (H/CL) ratio were determined in all patients as recommended.
RESULTS: PYP images from 35 patients (26%) were considered to be positive based on SPECT myocardial uptake. Among them, 20 (57%) had a H/CL ratio ≥1.5 and 34 had a visual score ≥ 2. SPECT identified myocardial uptake in one patient with a visual score < 2 and refuted the presence of myocardial uptake in two patients with a visual score ≥ 2. Visual score correlated well with SPECT (r = 0.94; P < .0001) and had an accuracy of 98% for tomographic myocardial uptake. Addition of H/CL ratio reduced the diagnostic performance of visual score.
CONCLUSIONS: Planar-derived visual score has an excellent accuracy for tomographic myocardial uptake, though it misclassifies a small proportion of patients. H/CL ratio decreases the diagnostic certainty of planar imaging. Tomographic imaging prevents misdiagnoses and should always be performed.

Entities:  

Keywords:  Amyloid heart disease; Image analysis; SPECT

Mesh:

Substances:

Year:  2020        PMID: 32901418     DOI: 10.1007/s12350-020-02328-5

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  3 in total

1.  The current status of quantitative SPECT/CT in the assessment of transthyretin cardiac amyloidosis.

Authors:  Stuart C Ramsay; Claire Cuscaden
Journal:  J Nucl Cardiol       Date:  2019-11-05       Impact factor: 5.952

2.  Value of SPECT imaging in patients with TTR-amyloid: ratios are not enough.

Authors:  Muzna Hussain; Patrick Collier; Wael Jaber
Journal:  J Nucl Cardiol       Date:  2019-12-19       Impact factor: 5.952

3.  Cases from a busy nuclear cardiology laboratory: Potential pitfalls in the interpretation of cardiac scintigraphy for ATTR cardiac amyloidosis.

Authors:  Ramsey M Wehbe; Preeti Kansal; Thomas A Holly
Journal:  J Nucl Cardiol       Date:  2020-05-07       Impact factor: 5.952

  3 in total
  6 in total

Review 1.  New Advanced Imaging Parameters and Biomarkers-A Step Forward in the Diagnosis and Prognosis of TTR Cardiomyopathy.

Authors:  Roxana Cristina Rimbas; Anca Balinisteanu; Stefania Lucia Magda; Simona Ionela Visoiu; Andrea Olivia Ciobanu; Elena Beganu; Alina Ioana Nicula; Dragos Vinereanu
Journal:  J Clin Med       Date:  2022-04-22       Impact factor: 4.964

2.  Optimal interpretation of Tc99m PYP in 2020: Avoiding the million-dollar mistake.

Authors:  Jaime Gerber; Edward J Miller
Journal:  J Nucl Cardiol       Date:  2021-01-13       Impact factor: 5.952

3.  A cardiology fellow's take-home points from ASNC's Webinar: Cases in Tc 99m-PYP evaluation of ATTR cardiac amyloidosis - interpretation and reporting.

Authors:  Mrinali Shetty
Journal:  J Nucl Cardiol       Date:  2021-03-02       Impact factor: 5.952

4.  Diagnostic performance of CMR, SPECT, and PET imaging for the detection of cardiac amyloidosis: a meta-analysis.

Authors:  Zhaoye Wu; Chunjing Yu
Journal:  BMC Cardiovasc Disord       Date:  2021-10-07       Impact factor: 2.298

Review 5.  Nuclear Imaging for the Diagnosis of Cardiac Amyloidosis in 2021.

Authors:  Weijia Li; Dipan Uppal; Yu-Chiang Wang; Xiaobo Xu; Damianos G Kokkinidis; Mark I Travin; James M Tauras
Journal:  Diagnostics (Basel)       Date:  2021-05-30

6.  Pitfalls of the Semi-Quantitative Analyzing 99mTc-Pyrophosphate Planar Images for Diagnosing Transthyretin Cardiac Amyloidosis: A Possible Solution.

Authors:  Yuankai Zhu; Ruping Pan; Dan Peng; Qingjian Dong; Xiaohua Zhu
Journal:  Diagnostics (Basel)       Date:  2022-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.